Elicio Therapeutics, Inc. 13D and 13G filings for Elicio Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-06-14 4:04 pm Purchase |
2023-06-01 | 13D | Elicio Therapeutics, Inc. ELTX |
Elicio Therapeutics Inc. ELTX |
319,527 3.700% |
319,527 (New Position) |
Filing |